Jason Ludlow, MD
Ophthalmology · Charleston, WVNPI 1588051791
Payments from drug & device makers
What this record shows
This record is dominated by other: $5,378 of the $7,845 with a category attached, or 68.6%. Alcon accounts for 83.1% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2023 at $5,782 and has fallen 87.1% since, to $744 in 2025. Among ophthalmology clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 84 payments — averaging $93.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$7K
- AbbVie$345
- Johnson & Johnson Surgical Vision, Inc.$330
- Sight Sciences, Inc.$133
- Amgen$114
- Mallinckrodt Hospital Products Inc.$101
- plus $304 from 11 others
What the payments were for
- Food & beverage$2,46731%
- Other$5,37869%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 35 | $6,518 |
| AbbVie(2 entities) | 12 | $345 |
| Johnson & Johnson Surgical Vision, Inc. | 10 | $330 |
| Sight Sciences, Inc. | 3 | $133 |
| Amgen | 5 | $114 |
| Mallinckrodt Hospital Products Inc. | 4 | $101 |
| Ivantis, Inc | 3 | $53 |
| Harrow Eye, LLC | 2 | $51 |
| Oyster Point Pharma, Inc. | 2 | $37 |
| Carl Zeiss Meditec USA, Inc. | 1 | $26 |
| Glaukos Corporation | 1 | $23 |
| Bausch & Lomb Americas Inc. | 1 | $23 |
| Rxsight Inc | 1 | $22 |
| Beaver-visitec International, Inc. | 1 | $21 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $17 |
| NEW World Medical,inc. | 1 | $17 |
| Thea Pharma Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Clareon$5,378
- Clareon PanOptix Pro$125
- Rocklatan$123
- Rhopressa$123
- ACTIVEFOCUS$120
- OMNI$109
- Tecnis 1-piece IOL$109
- AcrySof IQ PanOptix$106
How this compares
$7,845 in reported general payments places this provider in the 90th percentile of 85 ophthalmology providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 60 | $55,419 |
| LumiganBimatoprost | 41 | $18,360 |
| XiidraLifitegrast | 12 | $17,390 |
| RhopressaNetarsudil Mesylate | 26 | $10,682 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 359 | $7,086 |
| Prednisolone Acetate | 134 | $6,972 |
| CombiganBrimonidine Tartrate/Timolol | 23 | $6,877 |
| Travoprost | 31 | $6,269 |
| Latanoprost | 659 | $5,672 |
| CiloxanCiprofloxacin Hcl | 11 | $2,735 |
| Brimonidine Tartrate | 74 | $2,440 |
| Difluprednate | 12 | $2,417 |
| ErythromycinErythromycin Base | 218 | $2,200 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 155 | $1,690 |
| Fluorometholone | 18 | $1,271 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Combigan | $345 | $80,657124 claims |
| Bausch & Lomb Americas Inc.Xiidra | $23 | $17,39012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 85 ophthalmology providers in West Virginia.
Other ophthalmology in Charleston
- Joseph SinclairCharleston$9K
- Brian GriffithCharleston$9K
- Lawrence MinardiCharleston$7K
- Charity HixCharleston$6K
- James CaudillCharleston$521
- Paul FranckeCharleston$329
- Audrey HuntCharleston$305
- Michael NunleyCharleston$282
- Huseyin KadikoyCharleston$268
- Anthony RealiniMorgantown$410K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.